Dysregulation of Adult T-Cell Leukemia-Derived Factor (ADF)/Thioredoxin in HIV Infection: Loss of ADF High-Producer Cells in Lymphoid Tissues of AIDS Patients

AIDS Research and Human Retroviruses

Volumn 8, Issue 9, 1992, Pages 1707-1715

  Masutani, Hiroshi ^a   Naito, Makoto ^b   Takahashi, Kiyoshi ^b   Hattori, Toshio ^b   Koito, Atsushi ^b   Takatsuki, Kiyoshi ^b   go, Toshio ^a   Nakamura, Hajime ^a   Fujii, Shingo ^c   Yoshida, Yataroh ^a   Okuma, Minoru ^a   Yodoi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; THIOREDOXIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LYMPHOID TISSUE; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; T CELL LEUKEMIA; VIRUS CELL TRANSFORMATION; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS-RELATED COMPLEX; BLOTTING, WESTERN; CELL LINE; HIV INFECTIONS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MALE; MIDDLE AGE; NEOPLASM PROTEINS; SUPPORT, NON-U.S. GOV'T; THIOREDOXIN;

EID: 0026670591     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1992.8.1707     Document Type: Article

References (42)

1. Teshigawara K, Maeda M, Nishino K, Nikaido T, Uchiyama T, Tsudo M, Wano Y, and Yodoi J: Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol 1985;2:17–26.
2. Okada M, Maeda M, Tagaya Y, Taniguchi Y, Teshigawara K, Yoshiki T, Diamantstein T, Smith KA, Uchiyama T, Honjo T, and Yodoi J: TCGF(IL-2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL-2 receptor expression of HTLV-I(+) T cell lines. J Immunol 1985;135:3995–4003.
3. Tagaya Y, Okada M, Sugie K, Kasahara T, Kondo N, Hamuro J, Matsushima K, Dinarello CA, and Yodoi J: IL-2 receptor-Tac (p55) inducing factor: Purification and characterization of ATL-derived factor (ADF). J Immunol 1988;140:2613–2620.
4. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K-I, Yokota T, Wakasugi H, and Yodoi J: ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; Possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 1989;8:757–764.
5. Jones SW and Luk K-C: Isolation of a chicken thioredoxin cDNA clone. J Biol Chem 1988;263:9607–9611.
6. Johnson RS, Matthews WR, Biemann K, Hopperl S: Amino acid sequence of thioredoxin isolated from rabbit bone marrow determined by tandem mass spectrometry. J Biol Chem 1988;263:9589–9597.
7. Wollman EE, Auriol L, Rimsky L, Shaw A, Jacquot J-P, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F, Bertoglio J, and Fradelizi D: Cloning and expression of cDNA for human thioredoxin. J Biol Chem 1988;263:15506–15512.
8. Holmgren A: Thioredoxin. Annu Rev Biochem 1985;54:231–237.
9. Tagaya Y, Wakasugi H, Masutani H, Nakamura H, Iwata S, Mitsui A, Fujii S. Wakasugi N, Tursz T, and Yodoi J: Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: Involvement of dithiol related reduction. Molecular Immunol 1990;27:1279–1289.
10. Yodoi J and Tursz T: ADF: An endogenous reducing protein homologous to thioredoxin: Involvement in lymphocyte immortalization by HTLV-1 and EBV. Adv Cancer Res 1991;57: 381–411.
11. Wakasugi H, Rimsky R, Mahe Y, Kamel AM, Fradelizi D, Tursz T, and Bertoglio J: Epstein-Barr virus-containing B-cell line produced an interleukin 1 that it uses as a growth factor. Proc Natl Acad Sci (USA) 1987;84:804–808.
12. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, and Tursz T: ADF/Thioredoxin produced by both HTLV-I and EBV transformed lymphocytes acts as an autocrine growth factor and synergized with IL-1 and IL-2. Proc Natl Acad Sci (USA) 1990;87:8282–8286.
13. Carlsson M, Sunderstrom C, Bengtsson M, Totterman TH, Rozen A, Nilsson K: Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocyte leukemia cells depending on the co-stimulatory activation and progression signals. Eur J Immunol 1989;19:913–921.
14. Silberstein DS, Ali MH, Baker SL, and David JF: Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide. J Immunol 1989;143:979–988.
15. Rozell B and Hansson HA: Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell 1985;38:79–86.
16. Fujii S, Nanbu Y, Konishi I, Mori T, Masutani H, and Yodoi J: Immunohistochemical localization of adult T-cell leukemia-derived factor, a human thioredoxin homologue, in human fetal tissues. Virchows Archiv A Pathol Anat 1991;419:317.
17. Yamauchi A, Masutani H, Tagaya Y, Nakamura H, Inamoto T, Ozawa K, and Yodoi J: Lymphocyte transformation and dithiol compounds; The role of ADF/thioredoxin as an endogenous reducing agent. Mol Immunol 1992;29:263–270.
18. Rosenberg ZF and Fauci AS: Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990;11:176.
19. Matsuyama T, Kobayashi N, and Yamamoto N: Cytokine and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405.
20. Eck H-P, Gmünder H, Hartmann M, Petzoldt D, Daniel V, and Dröge W: Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler 1989;370:101–108.
21. Buhl R, Holyroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C, and Crystal RG: Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989;ii:1294–1297.
22. Suthanthiran M, Anderson ME, Sharma VK, and Meister A: Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci (USA) 1990;87:3343–3347.
23. Bannai S: Transport of cystine and cysteine in mammalian cells. Biochem Biophys Acia 1984;779:289–306.
24. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Slross WP, Gatter C, and Mason DY: KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989;42:414–421.
25. Vanstapel M-J, Gatter KC, de Wolf-Peeters C, Mason DY, and Desmet VD: New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol 1986;85: 160–168.
26. Hattori T, Sagawa K, Matsushita S, Koito A, Suto H, Matsuoka M, Yokoyama M, and Takatsuki K: Characterization of three monoclonal antibodies (VAK3–5) that identify p24, core protein of human immunodeficiency virus, and its precursors. JPN J Cancer Res 1987;78:235.
27. Biberfeld P, Östå, Porwit A, Sandstedt B, Pallesen G, Böttiger B, Morfelt-Månsson L, and Bberfeld G: Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Scand Ser C 1987;95:47–65.
28. Koito A, Shirono K, Suto H, Matsushita S, Hattori T, and Takatsuki K: Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B). Jpn J Can Res 1987;78:365–371.
29. Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493.
30. Towbin H, Staehelin T, and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: Procedure and some applications. Proc Natl Acad Sci (USA) 1979; 76:4350–4354.
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248–254.
32. Hentze MW, Rouault TA, Harford JB, and Klausner RD: Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 1989;244:357–359.
33. Abate C, Patel L, Rausher III FJ, and Curran T: Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 1990; 249:1157–1161.
34. Tenner-Racz K, Boefill M, Schulz-Meyer A, Dietrich M, Kern P, Weber J, Pinching AJ, Veronese-Dimarzo F, Popovic M, Klatzmann D, Gluckman JC, and Janossy G: HTLV-III/homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol 1986;123:9.
35. Mori S, Ezaki Y, Mori M, Takahashi M, Teshima M, and Sagawa K: Deterioration of B cell proliferation correlates with dendritic reticulum cell destruction in germinal centers of an AIDS patient case study. Acta Pathol Jan 1988;38:1205–1214.
36. Schinella RA, Muller WD, and Greco MA: The lymph node in AIDS: A light microscopic and ultrastructural study. In: Progress in AIDS pathology, vol. II. H. Rotterdam, P Racz, MA Greco, and CJ Cockerell (Eds.) Field and Wood, Medical Publishers, Inc., New York, 1990; 13–23.
37. Macatonia SE, Patteron S, and Knight SC: Suppression of immune responses by dendritic cells infected with HIV. Immunology 1989;67:285–289.
38. Garry RF: Potential mechanisms for the cytopathic properties of HIV. AIDS 1989;3:683.
39. Somasundaran M and Robinson HL: Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. Science 1988;242:1554.
40. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, and Herzenberg LA: Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci (USA) 1990;87:4884–4888.
41. Staal FJT, Roeder M, Israelski DM, Bupp J, Mole LA, Mcshane D, Deresinski SC, Ross W, Sussman H, Raju PA, Anderson MT, Moore W, Ela SW, Herzenberg LA, and Herzenberg LA: Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Human Retrovir 1992;8:305.
42. Horton R: Glutathione and HIV infection. Lancet 1990;335:234.